RSS
Jefferies Raises Price Target on Bristol Myers Squibb (BMY)
Analysts at Jefferies & Co. boosted the price target on pharmaceutical company Bristol Myers Squibb Co. (BMY
) on Tuesday, stating that 2013 will be a pivotal year for shaping long-term growth.
The analysts maintain a “Buy” rating on BMY and see shares reaching $41. This new target suggests an 11% upside to Monday’s closing price of $36.93.
Bristol Myers shares were down slightly during morning trading on Tuesday. The stock is up about +15% over the past year.
The Bottom Line
Shares of Bristol Myers (BMY) have a dividend yield of 3.79% based on last night’s closing price of $36.93 and the company’s annualized dividend payout of $1.40 per share.
Bristol Myers Squibb Co. (BMY) is recommended at this time, holding a Dividend.com DARS™ Rating of 3.5 out of 5 stars.
Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.
FREE Dividend Stock Newsletter
Get the Dividend.com email newsletter to receive:
- A free copy of our acclaimed report, 5 Rules of Winning Dividend Stock Investing
- Free daily investing tips and picks from Dividend.com CEO Paul Rubillo
- Tons of great market analysis and recommendations
MOST POPULAR ARTICLES ON DIVIDEND.COM
ABOUT THIS ARTICLE
THE BEST DIVIDEND STOCKS
Looking for stocks that are poised for growth and pay solid dividends? Visit our list of the 
ADVERTISING PARTNERS
